148.36 USD
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Biotech
Sector
USA
Investor locations
19/06/2006
Inception Date
1,120.14 mln USD
Total assets of the fund
0.56 %
Total Cost Ratio
NYSE Arca Biotechnology Index
Benchmark
First Trust
Provider
1,120.14 mln USD
Stock class assets
1 times per year
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
US33733E2037
ISIN
FBT
Ticker
CEOJLS
CFI